In a unanimous 21-to-0 vote last week, an advisory board for the U.S. Food and Drug Administration (FDA) recommended that the ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.

The U.S. Food and Drug Administration also asked its panel of external advisers to consider the usage of two COVID vaccine ...

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

The advisory panel mostly agreed with the FDA ... kids of immigrants COVID-19 vaccines have saved millions of lives and ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...